Active Ingredient: RILUZOLE
Proprietary Name: RILUZOLE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 50MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A206045
Product Number: 001
Approval Date: Dec 9, 2019
Applicant Holder Full Name: KENTON CHEMICALS AND PHARMACEUTICALS CORP
Marketing Status:
Prescription
Patent and Exclusivity Information